Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Mobile Cataract Units and Same-day Hip Replacements Helping Thousands Get NHS Treatment
Same-day hip replacements, one stop shops and mobile cataract units are just some of the […]
New State-Of-The-Art NHS Hospital To Help Tackle Covid Backlog
A new ‘planned care’ hospital dedicated to non-emergency treatment is due to open in Berkshire […]
NHS Fast Tracks New ‘Gamechanging’ Drug for Lung Cancer
A targeted new drug for a rare and aggressive form of lung cancer will be […]
NHS Strikes Deal to Make PKU Drug Available For All
The NHS is set to make a drug for the rare, debilitating disorder phenylketonuria (PKU) […]
Total NHS Covid Vaccines Top 96 Million, Amid Concern Over New Variant
Total Covid vaccinations in England have hit the 96 million mark as the NHS Covid-19 […]
Top Up Jab Bookings to Open Up For More Than One Million People
More than one million people will be eligible to book their life-saving jab top-up from […]
UK Government Secures Groundbreaking COVID-19 Antivirals
Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government […]
NHS Sets Out Next Stage of Covid Recovery Plan
Guidance to support hospitals with covid recovery over the next six months has been set […]
Innovation and New Technology to Help Reduce NHS Waiting Lists
Local surgical hubs, new technology to speed up diagnosis, and innovative ways of working will […]
Nationwide Roll-Out of NHS High Street Heart Checks to Save Thousands of Lives
Thousands of lives will be saved thanks to more blood pressure checks in high street […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more